Skip to content
Lower risk Drug recall · FDA · Published June 17, 2024

Trigen recalls 36mg Methylphenidate tablets due to failed dissolution specs

Trigen Laboratories recalls 36mg methylphenidate extended-release tablets (NDC 13811-708-10) because this batch failed dissolution tests. No remedy is specified in the recall notice.

🇺🇸 FDA recall #D-0579-2024DrugTrigen ›
Take action

Contact the company

Recalling firmTrigen Laboratories1880 Mcfarland Pkwy, ste 110 · Alpharetta, GA 30005-1794
✎ GovInfoNow plain-language explainer

Trigen Laboratories is recalling a specific batch of 36mg methylphenidate extended-release tablets due to failure in dissolution testing. This means the tablets may not release medication properly, potentially affecting treatment effectiveness. Read more at govinfonow.com/recall/32629-trigen-recalls-36mg-methylphenidate-tablets-due-to-failed-dissolution-specs.

Source Summary by GovInfoNow · govinfonow.com/recall/32629-trigen-recalls-36mg-methylphenidate-tablets-due-to-failed-dissolution-specs · Updated August 17, 2026 · FDA enforcement record: FDA #D-0579-2024

Cite this page

“Trigen recalls 36mg Methylphenidate tablets due to failed dissolution specs.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32629-trigen-recalls-36mg-methylphenidate-tablets-due-to-failed-dissolution-specs. Based on FDA recall #D-0579-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0579-2024%22&limit=1).

Trigen Laboratories voluntarily recalled Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count bottles due to failed dissolution specifications, according to the FDA on June 17, 2024.

How to tell if you have it

  • Brand: Trigen
  • Product: Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle
  • NDC: 13811-708-10
  • Lot: 230159M
  • Expiration Date: 2/28/2026
  • Quantity: 10,448 bottles
  • Distribution: Nationwide in the USA

The hazard

The product failed to meet dissolution specifications, according to the FDA.

Context

GovInfoNow's records show other recent recalls of similar products include Viatris Xanax XR 3mg Tablets Recall (2026-03-17), Teva Metoprolol Succinate Tablets Recall (2026-01-29), and Teva Metoprolol Succinate Extended-Release Tablets Recall (2026-01-29).

How to tell if you have this one

Check for the product name 'Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle' with NDC 13811-708-10 and lot number 230159M. This batch was manufactured by Trigen Laboratories in Alpharetta, GA.

  • Brand
    Trigen
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the NDC code 13811-708-10 and lot number 230159M on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Jun 17, 202412. FDA classified it Class II: Jul 2, 202423. Published in FDA’s Enforcement Report: Jul 10, 202434. FDA terminated the recall: Sep 23, 2025420242025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0579-2024 (June 17, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0579-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA